Straub Pearlridge Clinic

Summary

Straub Pearlridge Clinic is a medical facility located in Aiea, Hawaii. This center is recognized for care of Breast Cancer, Lung Cancer, Prostate Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Straub Pearlridge Clinic is involved with conducting 14 clinical trials across 138 conditions. There are 4 research doctors associated with this hospital, such as Jeffrey L. Berenberg, Stuart Tsuji, MD, Teruo Yamauchi, and Charles O. Kim.

Top PIs

Clinical Trials running at Straub Pearlridge Clinic

Breast Cancer

Breast cancer

Prostate Cancer

Colorectal Cancer

Melanoma

Non-Small Cell Lung Cancer

Cervical Adenocarcinoma

Cognitive Impairment

Mixed-Cell Lymphoma

Non-Hodgkin's Lymphoma

Chemotherapy + Hormone Therapy

for Breast Cancer

This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.

Recruiting

2 awards

Phase 3

19 criteria

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.

Recruiting

2 awards

Phase 3

47 criteria

Cognitive Training

for Breast Cancer Survivors

This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.

Recruiting

1 award

N/A

5 criteria